Mark Massaro
Stock Analyst at BTIG
(2.23)
# 1,522
Out of 4,433 analysts
98
Total ratings
45.95%
Success rate
n/a
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNGO Bionano Genomics | Maintains: Buy | $3 → $2 | $1.14 | +75.44% | 7 | May 16, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Sell | n/a | $0.81 | - | 4 | May 15, 2024 | |
| AKYA Akoya Biosciences | Maintains: Buy | $9 → $6 | $2.85 | +110.53% | 2 | May 14, 2024 | |
| NTRA Natera | Maintains: Buy | $100 → $125 | $106.46 | +17.41% | 6 | May 13, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $85 → $80 | $50.38 | +58.79% | 10 | May 9, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $23 → $21 | $14.80 | +41.89% | 4 | May 2, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $15 → $19 | $22.39 | -15.14% | 2 | Apr 30, 2024 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $6 → $5 | $3.61 | +38.50% | 2 | Apr 4, 2024 | |
| HLTH Cue Health | Downgrades: Neutral | n/a | $0.10 | - | 5 | Mar 14, 2024 | |
| MXCT MaxCyte | Maintains: Buy | $10 → $8 | $4.67 | +71.31% | 3 | Mar 13, 2024 | |
| TKNO Alpha Teknova | Downgrades: Neutral | n/a | $1.79 | - | 1 | Mar 12, 2024 | |
| DMTK DermTech | Maintains: Buy | $4 → $2 | $0.50 | +300.40% | 4 | Mar 7, 2024 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $8 | $2.88 | +177.78% | 8 | Mar 7, 2024 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $7 → $8 | $4.54 | +76.21% | 2 | Mar 6, 2024 | |
| TLIS Talis Biomedical | Maintains: Sell | $0.35 → $5 | $8.98 | -44.32% | 3 | Aug 16, 2023 | |
| CSTL Castle Biosciences | Maintains: Buy | $38 → $30 | $24.24 | +23.76% | 2 | Jun 15, 2023 | |
| RNLX Renalytix | Maintains: Buy | $4 → $3.5 | $0.51 | +582.13% | 3 | Apr 3, 2023 | |
| XGN Exagen | Maintains: Buy | $6 → $5 | $1.88 | +165.96% | 3 | Mar 22, 2023 | |
| CDNA CareDx | Maintains: Buy | $28 → $25 | $15.50 | +61.29% | 2 | Feb 28, 2023 | |
| GH Guardant Health | Maintains: Buy | $60 → $50 | $25.36 | +97.16% | 1 | Feb 24, 2023 | |
| CERS Cerus | Downgrades: Neutral | n/a | $1.97 | - | 1 | Jan 20, 2023 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $5 → $3.5 | $0.91 | +286.74% | 2 | Nov 18, 2022 | |
| TTOO T2 Biosystems | Downgrades: Neutral | n/a | $5.64 | - | 2 | Jul 7, 2022 | |
| OCX OncoCyte | Initiates: Buy | n/a | $2.93 | - | 1 | Nov 30, 2020 | |
| AXDX Accelerate Diagnostics | Initiates: Neutral | n/a | $0.88 | - | 1 | Oct 8, 2020 | |
| LH Laboratory Corporation of America Holdings | Maintains: Hold | n/a | $213.13 | - | 4 | Dec 3, 2018 | |
| DGX Quest Diagnostics | Maintains: Buy | n/a | $144.34 | - | 3 | Oct 24, 2018 | |
| HOLX Hologic | Maintains: Hold | n/a | $75.02 | - | 3 | Sep 27, 2018 | |
| QDEL QuidelOrtho | Maintains: Buy | n/a | $42.82 | - | 4 | Sep 10, 2018 | |
| ILMN Illumina | Maintains: Buy | n/a | $111.07 | - | 3 | Jul 31, 2018 |
Bionano Genomics
May 16, 2024
Maintains: Buy
Price Target: $3 → $2
Current: $1.14
Upside: +75.44%
Ginkgo Bioworks Holdings
May 15, 2024
Downgrades: Sell
Price Target: n/a
Current: $0.81
Upside: -
Akoya Biosciences
May 14, 2024
Maintains: Buy
Price Target: $9 → $6
Current: $2.85
Upside: +110.53%
Natera
May 13, 2024
Maintains: Buy
Price Target: $100 → $125
Current: $106.46
Upside: +17.41%
Exact Sciences
May 9, 2024
Maintains: Buy
Price Target: $85 → $80
Current: $50.38
Upside: +58.79%
NeoGenomics
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $14.80
Upside: +41.89%
GeneDx Holdings
Apr 30, 2024
Maintains: Buy
Price Target: $15 → $19
Current: $22.39
Upside: -15.14%
Adaptive Biotechnologies
Apr 4, 2024
Maintains: Buy
Price Target: $6 → $5
Current: $3.61
Upside: +38.50%
Cue Health
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.10
Upside: -
MaxCyte
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $4.67
Upside: +71.31%
Alpha Teknova
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.79
Upside: -
DermTech
Mar 7, 2024
Maintains: Buy
Price Target: $4 → $2
Current: $0.50
Upside: +300.40%
MDxHealth
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.88
Upside: +177.78%
SOPHiA GENETICS
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $4.54
Upside: +76.21%
Talis Biomedical
Aug 16, 2023
Maintains: Sell
Price Target: $0.35 → $5
Current: $8.98
Upside: -44.32%
Castle Biosciences
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $24.24
Upside: +23.76%
Renalytix
Apr 3, 2023
Maintains: Buy
Price Target: $4 → $3.5
Current: $0.51
Upside: +582.13%
Exagen
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $1.88
Upside: +165.96%
CareDx
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $15.50
Upside: +61.29%
Guardant Health
Feb 24, 2023
Maintains: Buy
Price Target: $60 → $50
Current: $25.36
Upside: +97.16%
Cerus
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.97
Upside: -
Lucid Diagnostics
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $0.91
Upside: +286.74%
T2 Biosystems
Jul 7, 2022
Downgrades: Neutral
Price Target: n/a
Current: $5.64
Upside: -
OncoCyte
Nov 30, 2020
Initiates: Buy
Price Target: n/a
Current: $2.93
Upside: -
Accelerate Diagnostics
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $0.88
Upside: -
Laboratory Corporation of America Holdings
Dec 3, 2018
Maintains: Hold
Price Target: n/a
Current: $213.13
Upside: -
Quest Diagnostics
Oct 24, 2018
Maintains: Buy
Price Target: n/a
Current: $144.34
Upside: -
Hologic
Sep 27, 2018
Maintains: Hold
Price Target: n/a
Current: $75.02
Upside: -
QuidelOrtho
Sep 10, 2018
Maintains: Buy
Price Target: n/a
Current: $42.82
Upside: -
Illumina
Jul 31, 2018
Maintains: Buy
Price Target: n/a
Current: $111.07
Upside: -